The Latest Cardiac and Vascular News
MILWAUKEE, July 1, 2020 /PRNewswire/ — Mpirik, an A.I. healthcare technology company that develops automated patient screening models for cardiovascular disease to drive actionable knowledge, quality and research, has named Dr. Daniel O’Hair as its Chief Medical Officer. For more than 20 years Dr. Daniel O’Hair has practiced as a Cardiovascular Surgeon, thought leader and scientific innovator […]
GOTHENBURG, Sweden, July 1, 2020 /PRNewswire/ — Mentice AB (STO: MNTC) today announced the appointment of Thanos Karras as the company’s new General Manager for Americas. Thanos’ appointment will play a critical role in supporting Mentice’s continual growth strategy and will help accelerate its leadership position in high fidelity endovascular simulation solutions. Vice President […]
Former President and CEO of the North American division of AstraZeneca Plc to join as Independent Director Westport, CT, July 01, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Acceleron Pharma Inc. (Nasdaq: XLRN), a leading biopharmaceutical company in the discovery, development and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, today announced that it intends to offer and sell, subject to market and other conditions, $400 million of its common stock in an […]
$5.1M Series A Funding Led by Ajax Health Will Be Used to Develop First-in-Class Product Designed with Three-Dimensional, Independent Steerability to Deliver Reliable Access June 30, 2020 08:00 AM Eastern Daylight Time BALTIMORE–(BUSINESS WIRE)–Protaryx™ Medical, a company committed to reimagining access to the left atrium for transcatheter cardiac procedures, today […]
Westport, CT, June 29, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) and its majority-owned subsidiary, ViralClear Pharmaceuticals, Inc., today announced that it has closed on the sale of 2,187,500 shares of the Company’s common stock, at a purchase price of $8.00 per share, in a registered […]
VANCOUVER and MINNEAPOLIS, June 25, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), announced that it received written notification yesterday (the “Nasdaq Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with the minimum market value requirement set […]
NEW YORK, June 25, 2020 /PRNewswire/ — Espero BioPharma, Inc. is focused on the development of drugs for the treatment of cardiorenal diseases. The company, a private Delaware corporation, is the result of a 2017 business combination between Espero Pharmaceuticals, Inc. and Armetheon, Inc. The company’s portfolio of products includes: (i) tecarfarin, a Phase […]
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW PRESS RELEASE 25 JUNE 2020 07:00 CEST REGULATED INFORMATION Ghent, BELGIUM – 25 June 2020 – Sequana […]
EDEN PRAIRIE, Minn., June 25, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced the promotion of Nestor Jaramillo, Jr. to President and Chief Operating Officer, effective July 1, 2020. In his expanded role, […]
